tiprankstipranks
TG Therapeutics to Participate in the Jefferies Global Healthcare Conference
PremiumPress ReleasesTG Therapeutics to Participate in the Jefferies Global Healthcare Conference
2M ago
TG Therapeutics Announces Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024 Consortium of Multiple Sclerosis Centers Annual Meeting
PremiumPress Releases
TG Therapeutics Announces Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024 Consortium of Multiple Sclerosis Centers Annual Meeting
2M ago
TG Therapeutics Announces Schedule of Upcoming Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024 Consortium of Multiple Sclerosis Centers Annual Meeting
PremiumPress Releases
TG Therapeutics Announces Schedule of Upcoming Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024 Consortium of Multiple Sclerosis Centers Annual Meeting
2M ago
Unusually active option classes on open May 1st
PremiumThe FlyUnusually active option classes on open May 1st
3M ago
TG Therapeutics sees FY24 BRIUMVI U.S. revenue approximately $270M-$290M
PremiumThe Fly
TG Therapeutics sees FY24 BRIUMVI U.S. revenue approximately $270M-$290M
3M ago
TG Therapeutics sees Q2 BRIUMVI U.S. revenue approximately $65M
PremiumThe Fly
TG Therapeutics sees Q2 BRIUMVI U.S. revenue approximately $65M
3M ago
TG Therapeutics contact with VA ‘unequivocal win,’ says JPMorgan
PremiumThe FlyTG Therapeutics contact with VA ‘unequivocal win,’ says JPMorgan
3M ago
TG Therapeutics Announces Additional Data Presentations for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting
PremiumPress Releases
TG Therapeutics Announces Additional Data Presentations for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting
3M ago
TG Therapeutics announces additional data presentation for BRIUMVI
PremiumThe Fly
TG Therapeutics announces additional data presentation for BRIUMVI
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100